RRC ID 63144
著者 Sakuda T, Kubo T, Johan MP, Furuta T, Sakaguchi T, Adachi N.
タイトル Development of an Oncolytic Recombinant Vesicular Stomatitis Virus Encoding a Tumor-suppressor MicroRNA.
ジャーナル Anticancer Res
Abstract BACKGROUND:Attempts have been made to enhance systemic therapy for osteosarcoma. In our previous study, the systemic administration of a vesicular stomatitis virus (VSV) improved the survival rates of mice with osteosarcoma but did not improve the long-term survival of the animals.
MATERIALS AND METHODS:In the present study, we developed a novel oncolytic VSV by incorporating tumor-suppressor microRNA143 (rVSV-miR143) to compare the antitumor effects of various doses (10×10-4, 5×10-4, and 1×10-4 multiplicity of infection) of rVSV-miR143 with those of VSV in vitro.
RESULTS:The cytotoxicity and migration-inhibitory effects of rVSV-miR143 on the osteosarcoma cells were significantly higher than those of VSV alone at a dose of 5×10-4 multiplicity of infection, indicating that rVSV-miRNA143 enhances the antitumor effect at certain doses.
CONCLUSION:VSV incorporating tumor-suppressor miRNA143 demonstrated a synergistic antitumor effect on osteosarcoma cells in vitro.
巻・号 40(11)
ページ 6319-6325
公開日 2020-11-1
DOI 10.21873/anticanres.14652
PII 40/11/6319
PMID 33109569
MeSH Animals Cell Line, Tumor Cell Movement / genetics Gene Expression Regulation, Neoplastic Genes, Tumor Suppressor* Humans Mice MicroRNAs / genetics* MicroRNAs / metabolism Oncolytic Virotherapy Oncolytic Viruses / genetics* Osteosarcoma / genetics Osteosarcoma / pathology Recombination, Genetic / genetics* Vesicular stomatitis Indiana virus / genetics*
IF 1.994
リソース情報
ヒト・動物細胞 LM8(RCB1450)